Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

883 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis and impact of a multidisciplinary lymphoma virtual tumor board.
Habermann TM, Khurana A, Lentz R, Schmitz JJ, von Bormann AG, Young JR, Hunt CH, Christofferson SN, Nowakowski GS, McCullough KB, Horna P, Wood AJ, Macon WR, Kurtin PJ, Lester SC, Stafford SL, Chamarthy U, Khan F, Ansell SM, King RL. Habermann TM, et al. Among authors: khurana a. Leuk Lymphoma. 2020 Dec;61(14):3351-3359. doi: 10.1080/10428194.2020.1817432. Epub 2020 Sep 23. Leuk Lymphoma. 2020. PMID: 32967496 Free PMC article.
Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria.
King RL, Khurana A, Mwangi R, Fama A, Ristow KM, Maurer MJ, Macon WR, Ansell SM, Bennani NN, Kudva YC, Walker RC, Watt KD, Schwab TR, Kushwaha SS, Cerhan JR, Habermann TM. King RL, et al. Among authors: khurana a. Hemasphere. 2021 Sep 6;5(10):e640. doi: 10.1097/HS9.0000000000000640. eCollection 2021 Oct. Hemasphere. 2021. PMID: 34514344 Free PMC article.
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study.
Tun AM, Khurana A, Mwangi R, Link BK, Wang Y, Feldman AL, Thompson CA, Novak AJ, Villasboas JC, Thanarajasingam G, Farooq U, Syrbu S, Nowakowski GS, Witzig TE, Ansell SM, Rimsza LM, Cerhan JR, Habermann TM, Maurer MJ. Tun AM, et al. Among authors: khurana a. Blood Adv. 2022 Sep 13;6(17):5210-5221. doi: 10.1182/bloodadvances.2022007990. Blood Adv. 2022. PMID: 35849723 Free PMC article.
Barriers to enrollment in clinical trials of patients with aggressive B-cell NHL that progressed after CAR T-cell therapy.
Bezerra ED, Iqbal M, Munoz J, Khurana A, Wang Y, Maurer MJ, Bansal R, Hathcock MA, Bennani N, Murthy HS, Rosenthal AC, Paludo J, Villasboas JC, Johnston PB, Habermann TM, Ansell SM, Castro JE, Witzig TE, Kharfan-Dabaja MA, Nowakowski GS, Lin Y. Bezerra ED, et al. Among authors: khurana a. Blood Adv. 2023 Apr 25;7(8):1572-1576. doi: 10.1182/bloodadvances.2022007868. Blood Adv. 2023. PMID: 36219588 Free PMC article. No abstract available.
883 results